Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2021-09-15
2022-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aims, purpose, or objectives:
Our objective is to reduce loneliness and increase quality of life for patients residing in residential care facilities and for high school students.
Background (Include relevant experience, gaps in current knowledge, preliminary data, etc.):
In response to the Covid pandemic, to protect their residents, residential care facilities have implemented restrictions limiting visitors as well as social activities. Anecdoctally this has negative impacted the quality of life of those residents, increasing their loneliness. Previous studies have shown positive impact of intergenerational programs including penpal programs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Penpal Program to Alleviate Loneliness
A social program connecting patients in residential care facilities with high school students through monthly letter writing would positively impact quality of life for both, reducing quantitative and qualitative measures of loneliness
Letters to increase social connection with goal to alleviate loneliness
Our hypothesis is that a social program connecting patients in residential care facilities with high school students through monthly letter writing would positively impact quality of life for both, reducing quantitative and qualitiative measures of loneliness
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Letters to increase social connection with goal to alleviate loneliness
Our hypothesis is that a social program connecting patients in residential care facilities with high school students through monthly letter writing would positively impact quality of life for both, reducing quantitative and qualitiative measures of loneliness
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Measured via their most recent cognitive assessment;
* Subjectively measured via nursing staff.
* High school students will be invited via recommendation of their instructors and school administrative staff:
* Parental permission will be required.
Exclusion Criteria
* Residents who lack decision-making capacity.
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Susan B. Laabs
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan Laabs, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-009976
Identifier Type: -
Identifier Source: org_study_id